Michelle has decades of compensation and benefits experience and has helped more than 100 companies in the life science and technology industries. Her experience includes hundreds of mergers and acquisitions, initial public offerings and other corporate transactions. Michelle also has extensive experience counseling mature public companies regarding their compensation and benefits programs.

Michelle’s most recent transactional experience includes:

  • US$3 billion public company acquisition as the buyer
  • US$282 million initial public offering as the issuer 
  • US$3.6 billion sale of public company as the seller 
  • US$175 million initial public offering as the issuer 
  • US$3.2 billion public company acquisition as the buyer
  • US$230 million initial public offering as the issuer